Stereotactic radiofrequency ablation as first-line treatment of recurrent HCC following hepatic resection

P Schullian, G Laimer, D Putzer, E Levy… - European Journal of …, 2020 - Elsevier
Background To evaluate the therapeutic efficacy, safety and overall clinical outcome of
multiprobe stereotactic RF ablation (SRFA) as first-line treatment of HCC recurrence after …
被引用次数：14 相关文章

Stereotactic radiofrequency ablation as first-line treatment of recurrent HCC following hepatic resection

P Schullian, G Laimer, D Putzer… - … journal of surgical …, 2020 - pubmed.ncbi.nlm.nih.gov
Background To evaluate the therapeutic efficacy, safety and overall clinical outcome of
multiprobe stereotactic RF ablation (SRFA) as first-line treatment of HCC recurrence after …

Stereotactic radiofrequency ablation as first-line treatment of recurrent HCC following hepatic resection

P Schullian, G Laimer, D Putzer, E Levy… - European Journal of …, 2020 - ejso.com
Background To evaluate the therapeutic efficacy, safety and overall clinical outcome of
multiprobe stereotactic RF ablation (SRFA) as first-line treatment of HCC recurrence after …

Stereotactic radiofrequency ablation as first-line treatment of recurrent HCC following hepatic resection.

P Schullian, G Laimer, D Putzer, E Levy… - European Journal of …, 2020 - europepmc.org
Background To evaluate the therapeutic efficacy, safety and overall clinical outcome of
multiprobe stereotactic RF ablation (SRFA) as first-line treatment of HCC recurrence after …